ArticleInfection2026
Follow-up blood cultures in Gram-negative bloodstream infections: predictors of collection and association with mortality-a two-centre cohort study.
Article in Infection, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionGiven the high morbidity and mortality of Gram-negative bloodstream infections (GN-BSI), follow-up blood cultures (FUBCs) have received increasing attention in clinical practice. However, evidence on their impact remains conflicting. This study assessed the association of FUBCs with 90-day all-cause mortality, accounting for immortal time bias.
methodsThis retrospective cohort study included 637 hospitalized adults with GN-BSI from two Swiss tertiary-care hospitals (April 2022-April 2024). FUBCs were defined as blood cultures obtained after availability of the index culture result up to 168 h after collection. Endpoints included predictors of FUBC collection and association with 90-day mortality. Sensitivity analyses evaluated FUBCs collected 48-120 h after the index culture.
resultsMean age was 71.3 years and 46% were female. Most infections were community-acquired (81%), predominantly of genitourinary origin (53%). Overall, 90-day mortality was 12.6%. In 83.5% of FUBCs, no pathogen was isolated, and persistent GN-BSI was identified in 26/33 positive FUBC (13%). FUBC collection was associated with longer antibiotic therapy (median 14 vs. 10 days; p < 0.001), hospital stay (median 10 vs. 7 days; p < 0.001) and higher 90-day mortality (18 vs. 10%). Predictors of FUBC collection included intensive-care unit admission, cardiac devices or intravascular catheters, advanced chronic kidney disease, leukaemia, paralysis, hospital-acquired infection, COPD, and non-urinary/non-biliary sources. Regarding the primary outcome, FUBC collection was not associated with mortality after adjustment for cofounding variables (HR 1.41 [95% CI 0.89-2.23]. However, positive FUBCs were found to be an independent predictor of increased 90-day mortality.
conclusionFUBCs were markers of disease severity but were not independently associated with mortality, while being linked to prolonged antibiotic use and hospitalization.
Indexed as
Identifiers
42658413What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.